Skip to content

COVID-19 Resources

Access the latest information on COVID-19 for clinical researchers
  • Home
  • About
    • NIH Collaboratory
      • Coordinating Center
      • NIH Collaboratory Trials
      • Core Working Groups
      • Steering Committee
      • Distributed Research Network
      • Our Impact
    • Living Textbook
      • Table of Contents
      • How to Use This Site
  • Resources
    • Data and Resource Sharing
    • Training Resources
    • Tools for Researchers
    • Publications
    • Knowledge Repository
  • Webinar
  • Podcast
  • News
    • News Feed
    • Calendar
    • Subscribe
return to home
Subscribe to Newsletter go to twitter feed go to linkedin go to blue sky feed
Search
NIH Collaboratory
Living Textbook of
Pragmatic Clinical Trials

COVID-19 Resources

Access the latest information on COVID-19 for clinical researchers
home button

Rethinking Clinical Trials

A Living Textbook of Pragmatic Clinical Trials

  • Design
    • What is a Pragmatic Clinical Trial?
    • Decentralized Pragmatic Clinical Trials
    • Developing a Compelling Grant Application
    • Experimental Designs and Randomization Schemes
    • Endpoints and Outcomes
    • Analysis Plan
    • Using Electronic Health Record Data
    • Building Partnerships and Teams to Ensure a Successful Trial
    • Intervention Delivery and Complexity
    • Patient Engagement
  • Data, Tools & Conduct
    • Assessing Feasibility
    • Acquiring Real-World Data
    • Assessing Fitness-for-Use of Real-World Data
    • Study Startup
    • Participant Recruitment
    • Monitoring Intervention Fidelity and Adaptations
    • Patient-Reported Outcomes
    • Clinical Decision Support
    • Mobile Health
    • Electronic Health Records–Based Phenotyping
    • Navigating the Unknown
  • Dissemination & Implementation
    • Data Sharing and Embedded Research
    • Dissemination Approaches for Different Audiences
    • Implementation
    • End-of-Trial Decision-Making
  • Ethics & Regulatory
    • Privacy Considerations
    • Identifying Those Engaged in Research
    • Collateral Findings
    • Consent, Disclosure, and Non-Disclosure
    • Data and Safety Monitoring
    • Ethical Considerations of Data Sharing in Pragmatic Clinical Trials
    • Ethics for AI and ML
    • IRB Responsibilities and Procedures

Introduction

CHAPTER SECTIONS

Choosing and Specifying Endpoints and Outcomes


Section 1

Introduction

Expand Contributors

Lesley Curtis, PhD
Adrian F. Hernandez, MD, MHS
Kevin P. Weinfurt, PhD

Contributing Editor
Karen Staman, MS

For an explanatory trial, investigators can specify any outcome or endpoint, define the endpoint, and then measure it. The term outcome usually refers to the measured variable (e.g., peak volume of oxygen or PROMIS Fatigue score), whereas an endpoint refers to the analyzed parameter (e.g., change from baseline at 6 weeks in mean PROMIS Fatigue score). Even after a specific outcome is selected, it may be challenging to determine the best way to measure the effect of an intervention in terms of an analyzable endpoint, especially with pragmatic research where data are collected as part of routine care.

With pragmatic research, the endpoints and outcomes need to be available as part of routine care. Although the research question regarding the relative risks, benefits, and burdens of a specific intervention or activity will drive the selection of endpoints and outcomes, in a PCT, the selection must be balanced with an understanding of what is available in the electronic health record (EHR) or claims data and what additional resources will be needed to capture information not found in these sources.

Watch the video module: What do Endpoints and Outcomes Look Like in Pragmatic Clinical Trials

Some conditions can be objectively defined with a lab test, are straightforward to diagnose, and/or have International Classification of Diseases (ICD) codes. Some conditions, such as a broken leg, almost certainly require medical intervention and are likely to be captured in an EHR. Other conditions, however, are more ambiguous or less severe, and patients might not go to providers for treatment. Events or conditions that are not medically attended are unlikely to be captured in an EHR.

Defining endpoints and outcomes for some health phenomena is relatively easy for things like

  • acute myocardial infarction
  • broken bone
  • hospitalization

However, many outcomes are not routinely recorded as part of healthcare delivery. For example:

  • suicide attempt
  • gout flare
  • silent myocardial infarction
  • early miscarriage

To detect these types of outcomes in pragmatic research, some additional work may be necessary, which might move the outcome ascertainment aspect in a less pragmatic direction.
Key questions include:

  • What challenges do you anticipate in trying to ascertain the endpoint?
  • How might you address the challenges?

In this chapter, we will discuss endpoints and outcomes in pragmatic trials.

  • Meaningful endpoints
  • Outcomes measured via the electronic health record
  • Impatient endpoints
  • Using death as an endpoint
  • Outcomes measured using digital health technology
  • Outcomes measured via direct patient report

SECTIONS

CHAPTER SECTIONS

sections

  1. Introduction
  2. Meaningful Endpoints
  3. Outcomes Measured via the Electronic Health Record
  4. Inpatient Endpoints in Pragmatic Clinical Trials
  5. Using Death as an Endpoint
  6. Outcomes Measured via Digital Health Technology
  7. Outcomes Measured via Direct Patient Report


Version History

March 11, 2026: Updated as part of annual review (changes made by K. Staman).

February 22, 2024: Updated video module (changes made by K. Staman)

September 30, 2022: Made minor nonsubstantive text edits (changes made by K. Staman and L. Stewart)

January 22, 2021: Added embedded video (change made by G. Uhlenbrauck).

July 2, 2020: Minor corrections to layout and formatting (changes made by D. Seils).

December 4, 2018: Added key questions (changes made by K. Staman).

Published August 25, 2017

current section :

Introduction

  1. Introduction
  2. Meaningful Endpoints
  3. Outcomes Measured via the Electronic Health Record
  4. Inpatient Endpoints in Pragmatic Clinical Trials
  5. Using Death as an Endpoint
  6. Outcomes Measured via Digital Health Technology
  7. Outcomes Measured via Direct Patient Report

Citation:

Curtis L, Hernandez A, Weinfurt K. Choosing and Specifying Endpoints and Outcomes: Introduction. In: Rethinking Clinical Trials: A Living Textbook of Pragmatic Clinical Trials. Bethesda, MD: NIH Pragmatic Trials Collaboratory. Available at: https://rethinkingclinicaltrials.org/chapters/design/choosing-specifying-end-points-outcomes/choosing-and-specifying-endpoints-and-outcomes-introduction/. Updated March 11, 2026. DOI: 10.28929/009.

Footer Menu

  • How to Use This Site
  • About NIH Collaboratory
  • Enrollment Reporting
  • Grand Rounds
  • Funding Statement
Link to Twitter Link to LinkedIn Link to Blue Sky Link to NIH Collaboratory email

Reference in this Web site to any specific commercial products, process, service, manufacturer, or company does not constitute its endorsement or recommendation by the U.S. Government or National Institutes of Health (NIH). NIH is not responsible for the contents of any “off-site” Web page referenced from this server.

Log in
Privacy Statement
WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly. Site Map